Humira Buyers Get Backing Against AbbVie's 'Patent Thicket'

By Bryan Koenig · October 13, 2020, 9:09 PM EDT

Consumer advocates, academics and a drug store industry group all have urged the Seventh Circuit to revive a lawsuit claiming AbbVie built an anti-competitive "patent thicket" around its blockbuster immunosuppressant Humira...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Mayor and City Council of Baltimore, et al v. AbbVie Inc., et al

Case Number

Court

Appellate - 7th Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 30, 2020

Recent Articles By Bryan

July 08, 2024
Texas Anesthesia Co. Can't Pause Or Appeal Suit, FTC Says
June 27, 2024
EU High Court Upends Servier Decrease Of Pay-For-Delay Fine
June 26, 2024
Apple Watch Improvement Is 'Inferior,' Docs Tell 9th Circ.
June 13, 2024
EU Makes First Ever Formal Pharma Price-Fixing Complaint
June 12, 2024
Texas Anesthesia Co. Appealing To Duck FTC Suit To 5th Circ.
June 10, 2024
Rehab Clinics Add To MultiPlan Insurance Fixing Pile-On
May 22, 2024
Teva, Bristol-Myers Cite Bystolic Against Cancer Drug Case
May 14, 2024
FTC Cleared To Sue Texas Anesthesia Co., But Not PE Firm
May 09, 2024
DOJ Task Force To Target Healthcare Monopoly, Collusion
May 07, 2024
$55M Hospital Merger Suit Deal OK'd, UHC Objection Rejected